Francesco Artoni
University of Verona, Azienda Ospedaliera Universitaria Integrata Verona
Papers
12
Total Citations
100
H-Index
5
About
Francesco Artoni is a urologic surgeon and clinical researcher whose work centers on advancing robotic surgery for prostate and kidney cancers. His major contributions come from the COMPAR-P trial, a landmark prospective study directly comparing the Hugo RAS and da Vinci Xi platforms during radical prostatectomy. Across 100 consecutive cases, Artoni and his team provided granular data on intraoperative performance, malfunction rates, and user satisfaction—a first-of-its-kind head-to-head analysis with 36 citations. He has also refined surgical technique in robotic partial nephrectomy, comparing transperitoneal versus retroperitoneal approaches with a focus on patient-centered outcomes like mobilization and pain (14 citations). Beyond technique, Artoni has validated prognostic tools such as the 2012 Briganti nomogram, showing it independently predicts disease progression in intermediate- and high-risk prostate cancer patients—work that has already accumulated multiple citations in 2024 alone. His research consistently bridges surgical precision with meaningful patient recovery metrics, establishing him as a rising authority in robotic urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10